Emphysema Treatment Global Market Report 2025

Description

Emphysema treatment refers to medication for chronic obstructive pulmonary disease (COPD), a condition that leads to damage in the air sacs of the lungs, resulting in difficulty breathing. Treatments for emphysema aim to manage symptoms and slow the progression of the disease.

The primary treatments for emphysema include smoking cessation, bronchodilators, steroids, leukotriene modifiers, supplemental oxygen, antibiotics, gene therapy, surgery transplant, and others. Smoking cessation involves the cessation of smoking to reduce the risk of cancer and other significant health issues. This process helps minimize cravings and withdrawal symptoms while preventing nicotine binding. These treatments are available through various distribution channels, including online providers, drug stores, retail pharmacies, and hospital pharmacies. They are utilized by various end-users such as clinics, surgical centers, and others.

The emphysema treatment market research report is one of a series of new reports from The Business Research Company that provides emphysema treatment market statistics, including emphysema treatment industry global market size, regional shares, competitors with an emphysema treatment market share, detailed emphysema treatment market segments, market trends and opportunities, and any further data you may need to thrive in the emphysema treatment industry. This emphysema treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The emphysema treatment market size has grown strongly in recent years. It will grow from$5.15 billion in 2024 to $5.43 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to the smoking epidemic impact, advancements in medications, pulmonary rehabilitation programs, improved diagnostic tools, awareness and education

The emphysema treatment market size is expected to see strong growth in the next few years. It will grow to $7.4 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to aging population trends, customized treatment approaches, expanded access to therapies, focus on symptom management, and collaborative healthcare models. Major trends in the forecast period include the exploration of gene therapies, patient education and empowerment, integration of artificial intelligence (AI), increased accessibility to treatment, and long-acting medications development.

The increasing prevalence of chronic obstructive pulmonary disease (COPD) is anticipated to drive the growth of the emphysema treatment market in the future. COPD encompasses a range of disorders that lead to airflow obstruction and breathing difficulties, including emphysema and chronic bronchitis. Emphysema therapies are crucial for slowing the progression of COPD, as they aim to alleviate symptoms, restore lung function, and delay disease advancement. For example, reports from the Australian Institute of Health and Welfare (AIHW), an Australian agency, indicate that in 2022, approximately 638,000 individuals, or 2.5% of Australia's population, were living with COPD. By 2023, COPD accounted for 3.6% of the overall disease burden, representing 50% of the total burden associated with respiratory conditions. Additionally, in 2022, COPD was the underlying cause of 7,691 deaths, which translates to 29.6 deaths per 100,000 people and constitutes 4.0% of all deaths in the country. Consequently, the rise in COPD cases is driving demand in the emphysema treatment market.

The rise in air pollution is projected to drive the growth of the emphysema treatment market in the coming years. Air pollution refers to the presence of harmful or undesirable substances in the air, which can negatively impact both the environment and human health. Increased levels of particulate matter and toxic gases can worsen respiratory conditions, including chronic obstructive pulmonary disease (COPD) such as emphysema. Higher exposure to air pollutants may lead to a surge in respiratory diseases, thereby increasing the demand for emphysema treatments. For instance, reports from the Environmental Protection Agency (EPA), a US federal agency, indicate that in 2023, around 66 million tons of pollutants were emitted into the atmosphere in the United States. As a result, the growing levels of air pollution are contributing to the expansion of the emphysema treatment market.

Prominent companies in the emphysema market are striving to gain a competitive advantage by developing minimally invasive procedures tailored for emphysema patients. Minimally invasive procedures involve medical interventions or surgical techniques that aim to cause minimal disruption to the body's normal structures. For example, in January 2022, Adena Health System, a healthcare company based in the United States, introduced Zephyr Valve surgery as a minimally invasive alternative to traditional lung volume reduction surgery for individuals experiencing lung hyperinflation, a common issue in emphysema and COPD. This innovative procedure involves the placement of small, one-way Zephyr Valves in the lungs' airways through a bronchoscope. These valves facilitate the release of trapped air, preventing further accumulation and enabling healthier lung areas to expand, thereby improving breathing.

Leading companies in the emphysema market are also focusing on the development of innovative products, such as inhalation aerosols, to establish a competitive edge. Inhalation aerosols are pharmaceutical formulations dispensed as a fine mist or spray of liquid medication suspended in a propellant or propellant mixture. For instance, in July 2023, Viatris Inc., a U.S.-based pharmaceutical company, in collaboration with Kindeva Drug Delivery L.P., a U.S.-based pharmaceutical contract development and manufacturing organization (CDMO), launched Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol. This marks the first FDA-approved generic version of AstraZeneca's Symbicort, catering to patients managing asthma, chronic obstructive pulmonary disease (COPD), and emphysema. Breyna, available in various dosage strengths, signifies a crucial advancement in providing accessible and cost-effective treatment options for individuals facing respiratory challenges.

In March 2023, UC Davis Health, an academic health institution based in the United States, entered into a collaboration with Propeller Health to offer individualized treatment for chronic obstructive pulmonary disease (COPD) and asthma through remote patient monitoring technology. This partnership allows UC Davis Health to provide eligible patients with Propeller Health's remote patient monitoring (RPM) service, delivering personalized therapy for high-risk COPD and asthma patients using sensors, a smartphone application, and a website. Propeller Health, a U.S.-based mobile platform company, provides sensors, mobile apps, analytics, and services to assist in respiratory health management.

Major companies operating in the emphysema treatment market include AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Mylan N.V., Pfizer Inc., Orion Oyj, Verona Pharma PLC, Pulmonx Corporation, Emphasys Medical Inc., Halozyme Therapeutics Inc., Mariposa Health Limited, Uptake Technologies Inc., Respinova Ltd, Gala Therapeutics Inc., Pulmatrix Inc., Broncus Medical Inc., Holaira Inc., PneumRx Inc., Spiration Inc., Aeris Therapeutics Inc., CSA Medical Inc., Olympus Corporation

North America was the largest region in the emphysema treatment market in 2024. The regions covered in the emphysema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the emphysema treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The emphysema treatment market includes revenues earned by entities by providing medical services such as bronchodilator medications, anti-inflammatory medication, oxygen therapy, lifestyle change consultation, and interventional therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Emphysema Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on emphysema treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for emphysema treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The emphysema treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Treatment: Smoking Cessation; Bronchodilators; Steroids; Leukotriene Modifiers; Supplemental Oxygen; Antibiotics; Gene Therapy; Surgery Transplant; Other Treatments
2) By Distribution Channel: Online Providers; Drug Stores and Retail Pharmacies; Hospital Pharmacies
3) By End-User: Clinics; Surgical Centre; Other End-Users
Subsegments:
1) By Smoking Cessation: Nicotine Replacement Therapy (NRT); Prescription Medications; Behavioral Therapy Programs
2) By Bronchodilators: Short-Acting Beta-Agonists (SABAs); Long-Acting Beta-Agonists (LABAs); Anticholinergics
3) By Steroids: Inhaled Corticosteroids (ICS); Oral Corticosteroids; Combination Inhalers
4) By Leukotriene Modifiers: Montelukast; Zafirlukast
5) By Supplemental Oxygen: Portable Oxygen Concentrators; Continuous Flow Oxygen Systems; Pulse Dose Oxygen Systems
6) By Antibiotics: Macrolides; Fluoroquinolones; Tetracyclines
7) By Gene Therapy: Gene Replacement Therapy; Antisense Oligonucleotides
8) By Surgery Transplant: Lung Volume Reduction Surgery (LVRS); Lung Transplantation
9) By Other Treatments: Pulmonary Rehabilitation Programs; Nutritional Support; Palliative Care
Companies Mentioned: AstraZeneca PLC; Teva Pharmaceutical Industries Ltd.; Novartis AG; GlaxoSmithKline PLC; Hikma Pharmaceuticals PLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r24105

1. Executive Summary

2. Emphysema Treatment Market Characteristics

3. Emphysema Treatment Market Trends And Strategies

4. Emphysema Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Emphysema Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Emphysema Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Emphysema Treatment Market Growth Rate Analysis
5.4. Global Emphysema Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Emphysema Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Emphysema Treatment Total Addressable Market (TAM)

6. Emphysema Treatment Market Segmentation

6.1. Global Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Smoking Cessation
Bronchodilators
Steroids
Leukotriene Modifiers
Supplemental Oxygen
Antibiotics
Gene Therapy
Surgery Transplant
6.2. Global Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Online Providers
Drug Stores and Retail Pharmacies
Hospital Pharmacies
6.3. Global Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinics
Surgical Centre
Other End-Users
6.4. Global Emphysema Treatment Market, Sub-Segmentation Of Smoking Cessation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nicotine Replacement Therapy (NRT)
Prescription Medications
Behavioral Therapy Programs
6.5. Global Emphysema Treatment Market, Sub-Segmentation Of Bronchodilators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Short-Acting Beta-Agonists (SABAs)
Long-Acting Beta-Agonists (LABAs)
Anticholinergics
6.6. Global Emphysema Treatment Market, Sub-Segmentation Of Steroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inhaled Corticosteroids (ICS)
Oral Corticosteroids
Combination Inhalers
6.7. Global Emphysema Treatment Market, Sub-Segmentation Of Leukotriene Modifiers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Montelukast
Zafirlukast
6.8. Global Emphysema Treatment Market, Sub-Segmentation Of Supplemental Oxygen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Portable Oxygen Concentrators
Continuous Flow Oxygen Systems
Pulse Dose Oxygen Systems
6.9. Global Emphysema Treatment Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Macrolides
Fluoroquinolones
Tetracyclines
6.10. Global Emphysema Treatment Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gene Replacement Therapy
Antisense Oligonucleotides
6.11. Global Emphysema Treatment Market, Sub-Segmentation Of Surgery Transplant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lung Volume Reduction Surgery (LVRS)
Lung Transplantation
6.12. Global Emphysema Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pulmonary Rehabilitation Programs
Nutritional Support
Palliative Care

7. Emphysema Treatment Market Regional And Country Analysis

7.1. Global Emphysema Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Emphysema Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Emphysema Treatment Market

8.1. Asia-Pacific Emphysema Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Emphysema Treatment Market

9.1. China Emphysema Treatment Market Overview
9.2. China Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Emphysema Treatment Market

10.1. India Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Emphysema Treatment Market

11.1. Japan Emphysema Treatment Market Overview
11.2. Japan Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Emphysema Treatment Market

12.1. Australia Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Emphysema Treatment Market

13.1. Indonesia Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Emphysema Treatment Market

14.1. South Korea Emphysema Treatment Market Overview
14.2. South Korea Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Emphysema Treatment Market

15.1. Western Europe Emphysema Treatment Market Overview
15.2. Western Europe Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Emphysema Treatment Market

16.1. UK Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Emphysema Treatment Market

17.1. Germany Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Emphysema Treatment Market

18.1. France Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Emphysema Treatment Market

19.1. Italy Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Emphysema Treatment Market

20.1. Spain Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Emphysema Treatment Market

21.1. Eastern Europe Emphysema Treatment Market Overview
21.2. Eastern Europe Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Emphysema Treatment Market

22.1. Russia Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Emphysema Treatment Market

23.1. North America Emphysema Treatment Market Overview
23.2. North America Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Emphysema Treatment Market

24.1. USA Emphysema Treatment Market Overview
24.2. USA Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Emphysema Treatment Market

25.1. Canada Emphysema Treatment Market Overview
25.2. Canada Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Emphysema Treatment Market

26.1. South America Emphysema Treatment Market Overview
26.2. South America Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Emphysema Treatment Market

27.1. Brazil Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Emphysema Treatment Market

28.1. Middle East Emphysema Treatment Market Overview
28.2. Middle East Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Emphysema Treatment Market

29.1. Africa Emphysema Treatment Market Overview
29.2. Africa Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Emphysema Treatment Market Competitive Landscape And Company Profiles

30.1. Emphysema Treatment Market Competitive Landscape
30.2. Emphysema Treatment Market Company Profiles
- 30.2.1. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Hikma Pharmaceuticals PLC Overview, Products and Services, Strategy and Financial Analysis

31. Emphysema Treatment Market Other Major And Innovative Companies

31.1. Boehringer Ingelheim GmbH
31.2. Mylan N.V.
31.3. Pfizer Inc.
31.4. Orion Oyj
31.5. Verona Pharma PLC
31.6. Pulmonx Corporation
31.7. Emphasys Medical Inc.
31.8. Halozyme Therapeutics Inc.
31.9. Mariposa Health Limited
31.10. Uptake Technologies Inc.
31.11. Respinova Ltd
31.12. Gala Therapeutics Inc.
31.13. Pulmatrix Inc.
31.14. Broncus Medical Inc.
31.15. Holaira Inc.

32. Global Emphysema Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Emphysema Treatment Market

34. Recent Developments In The Emphysema Treatment Market

35. Emphysema Treatment Market High Potential Countries, Segments and Strategies

35.1 Emphysema Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Emphysema Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Emphysema Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer